Securities code: 600781 securities abbreviation: St Furen Announcement No.: 2022-012 Furen Group Pharmaceutical Co.Ltd(600781)
Announcement on the progress of shareholders’ share reduction
The board of directors, all directors and relevant shareholders of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents. Important content tips:
Basic information about the shareholding of major shareholders and directors, supervisors and senior executives: Shenzhen pingjiaxinyuan equity investment enterprise (limited partnership) (hereinafter referred to as “pingjiaxinyuan”) plans to reduce its shareholding. Pingjiaxinyuan holds 33398147 shares of the company, accounting for 5.33% of the total shares of the company.
Progress of the reduction plan: during the reduction period, Ping Jiaxinyuan reduced 2100000 shares, accounting for 0.34% of the total share capital of the company. After the disclosure of this announcement, Ping Jiaxinyuan held 31298147 shares of the company, accounting for 4.99% of the total shares of the company.
1、 Basic information of the reducing entity before the reduction
Number of shares held
Shareholder name shareholder identity current shareholding source
(share) ratio
More than 5% of Ping Jiaxin yuan is not the largest shareholder, and 5.33% is obtained through non-public offering: 33398147 shares
The above reduction subjects have no concerted action. 2、 Implementation progress of share reduction plan
(I) major shareholders (controlling shareholders of listed companies and shareholders holding more than 5% shares, hereinafter collectively referred to as “major shareholders”) and directors, supervisors and senior executives disclose the implementation progress of the reduction plan for the following reasons:
Reason for disclosure: the number of shares held ranges from more than 5% to less than 5%
Implementation progress:
Reduction price area
Number of holdings reduction ratio of holdings reduction total amount of holdings reduction current number of holdings name of current shareholder during the reduction period
(share) example mode (yuan) (share) share proportion (yuan / share)
2022 / 2 / 8 centralized
Pingjia
2100000 0.34% ~ bidding 2.95-3.13 6385403 31298147 4.99% Xinyuan
2022 / 2 / 21 transaction
(II) whether the reduction is consistent with the plans and commitments previously disclosed by major shareholders or directors, supervisors and senior executives
□ yes □ no
(III) whether the listed company has disclosed major issues such as high transfer or planning merger and reorganization within the reduction time period
□ yes √ no
(IV) impact of this reduction on the company
This reduction will not affect the governance structure and sustainable operation of listed companies.
3、 Relevant risk tips
(I) Ping Jiaxinyuan will choose whether to continue to implement the plan according to market conditions, the company’s share price and other factors
And how to implement the reduction plan. There is uncertainty risk in the reduction time and price.
(II) whether the implementation of the share reduction plan will lead to the risk of change of control of the listed company □ yes
√ no
(III) other risks
Ping Jiaxinyuan promises to strictly abide by the securities law and the listing regulations of Shanghai Stock Exchange
Several provisions on the reduction of shares held by shareholders, directors, supervisors and senior executives of listed companies, Shanghai Stock Exchange
Detailed rules for the implementation of share reduction by shareholders, directors, supervisors and senior managers of listed companies, etc
Provisions of laws, regulations and normative documents.
It is hereby announced.
Furen Group Pharmaceutical Co.Ltd(600781) board of directors
February 23, 2022
